0000886163-23-000068.txt : 20230925
0000886163-23-000068.hdr.sgml : 20230925
20230925181231
ACCESSION NUMBER: 0000886163-23-000068
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230922
FILED AS OF DATE: 20230925
DATE AS OF CHANGE: 20230925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zimmermann Martine
CENTRAL INDEX KEY: 0001994049
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 231276809
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INCORPORATED
STREET 2: 3911 SORRENTO VALLEY BOULEVARD SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
edgardoc.xml
PRIMARY DOCUMENT
X0206
3
2023-09-22
1
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001994049
Zimmermann Martine
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
1
0
0
0
Exhibit 24 - Power of Attorney
By: /s/ Andrew Reardon For: Martine Zimmermann
2023-09-25
EX-24
2
poa.txt
EDGAR SUPPORTING DOCUMENT
POWER OF ATTORNEY
With respect to holdings of and transactions in securities issued by
Ligand Pharmaceuticals Incorporated (the"Company"), the undersigned hereby
constitutes and appoints the individuals, and their respective successors,
holding the positions named on Schedule A attached hereto and as maybe amended
from time to time, or anyof them signing singly, with full power of
substitution and resubstitution, to act as the undersigned's true and lawful
attorney-in-fact to:
1. execute for and on behalf of the undersigned, Schedules 13D and 13G
in accordance with Section 13 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and the rules thereunder, and Forms
3, 4, and 5 in accordance with Section 16 of the Exchange Act and the
rules thereunder;
2. do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Schedule 13D or 13G or Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such schedule or form
with the SEC and any stock exchange or similar authority; and
3. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney- in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-
fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and petform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution and
resubstitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 13 and Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D and l3G and Forms 3, 4,
and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN, WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this l0 day of September 2023.
/s/ Martine Zimmermann
------------------------------
Martine Zimmermann
Schedule A
----------
Individuals Appointed as Attorney-in-Fact with Full Power of Substitution
and Resubstitution
*Chief Financial Officer - Octavio Espinoza
*Chief Operating Officer - Matthew Korenberg
*Chief Legal Officer - Andrew Reardon